Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China · Delayed Price · Currency is CNY 4.260
-0.090 (-2.07%)
Nov 6, 2026, 3:00 PM CST
SHA:600572 Revenue
Zhejiang CONBA Pharmaceutical had revenue of 1.63B CNY in the quarter ending September 30, 2026, with 0.71% growth. This brings the company's total for the last twelve months to 6.83B, up 3.80% year-over-year. In the year 2025, Zhejiang CONBA Pharmaceutical had annual revenue of 6.47B, down -0.64%. That makes Zhejiang CONBA Pharmaceutical the 7,542nd largest company in the world by revenue and 1,102nd in China.
Revenue (ttm)
6.83B
Revenue Growth
+3.80%
P/S Ratio
1.58
Revenue / Employee
872.45K
Employees
7,826
Market Cap
10.82B
Revenue by Segment
- Manufacturing Industry 5.58B 87.4%
- Business 806.37M 12.6%
Fiscal year ended Dec 31, 2025 See the full SHA:600572 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.47B | -41.73M | -0.64% |
| Dec 31, 2024 | 6.52B | -217.63M | -3.23% |
| Dec 31, 2023 | 6.73B | 732.35M | 12.20% |
| Dec 31, 2022 | 6.00B | -567.74M | -8.64% |
| Dec 31, 2021 | 6.57B | 659.17M | 11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.